Health & Fitness
Fri, March 2, 2012Thu, March 1, 2012Wed, February 29, 2012Tue, February 28, 2012Mon, February 27, 2012Sat, February 25, 2012Fri, February 24, 2012Thu, February 23, 2012Wed, February 22, 2012Tue, February 21, 20122012 Economic Outlook - Report Highlights Halozyme Therapeutics, Inc. and Masimo Corporation
Published in Health and Fitness on Monday, February 27th 2012 at 6:05 GMT by Market Wire
February 27, 2012 09:00 ET
2012 Economic Outlook - Report Highlights Halozyme Therapeutics, Inc. and Masimo Corporation
HONG KONG--(Marketwire - Feb 27, 2012) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting Halozyme Therapeutics, Inc. (
Economic fundamentals leading into 2012 have set a generally positive pace with GDP growth likely to pick up through the coming year. However, there are several important caveats to note as the world economy continues to face headwinds and risks weigh to the downside. Positive outlooks are conditional on fiscal policy in payroll taxes and unemployment insurance benefits and upon the easing of the European debt situation. A repeat of volatility experience in 2011 is likely in 2012, as perceptions about the strength of the U.S. economy and the euro zone will vary over time as events unfold.
Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.
Brighton Markets is releasing new coverage on Halozyme Therapeutics, Inc. for its current position within the healthcare industry. Halozyme Therapeutics, Inc. is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the diabetes, cancer, dermatology and drug delivery markets. The full research report on Halozyme Therapeutics, Inc. (
Brighton Markets has released research on Masimo Corporation for its changing role within the healthcare industry. Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products. It develops, manufactures and markets a patient monitoring solution that incorporates a monitor or circuit board and sensors, including single-patient use, reusable and ReSposable sensors and patient cables. The full research report on Masimo Corporation (
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.
